LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer — Stella

Home/Left-sided Pancreatic Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Left-sided Pancreatic Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality

Key details

Sponsor

Fudan University

Collaborators

The Third Affiliated Hospital of Soochow University, Qilu Hospital of Shandong University

Enrollment target

~160 participants

Started

October 2023

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated November 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.